Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Phibro Animal Health Corporation (PAHC) had Revenue of $363.89M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$363.89M
Net Income	$26.53M
Cost of Goods Sold	$244.11M
Gross Profit	$119.78M
Operating Expenses	$312.63M
Operating Income	$51.26M
Non-Operating Income/Expense	$-14.99M
Pre-Tax Income	$36.27M
Normalized Pre-Tax Income	$36.27M
Income after Taxes	$26.53M
Income from Continuous Operations	$26.53M
Consolidated Net Income/Loss	$26.53M
Normalized Income after Taxes	$26.53M
EBIT	$51.26M
EBITDA	$64.66M
Weighted-Average Shares Outstanding (Basic)	40.53M
Weighted-Average Shares Outstanding (Diluted)	40.88M
Earnings per Share (EPS) (Basic)	$0.65
Earnings per Share (EPS) (Diluted)	$0.65
Balance Sheet Financials
Current Assets	$835.80M
Property, Plant, and Equipment	$354.78M
Long-Term Assets	$549.73M
Total Assets	$1.39B
Current Liabilities	$270.14M
Long-Term Debt	$724.52M
Long-Term Liabilities	$803.70M
Total Liabilities	$1.07B
Common Equity	$311.68M
Tangible Shareholders Equity	$217.01M
Shareholders Equity	$311.68M
Common Shares Outstanding	40.56M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$9.30M
Cash Flow from Investing Activities	$-21.01M
Cash Flow from Financial Activities	$16.34M
Beginning Cash	$68.04M
End Cash	$72.77M
Increase/Decrease in Cash	$4.73M
Stock-Based Compensation	$0.34M
Common Stock Dividends Paid	$-4.86M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.09
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.70
Debt to Equity Ratio	2.38
Gross Margin	32.92%
Operating Margin	14.09%
EBIT Margin	14.09%
EBITDA Margin	--
Pre-Tax Profit Margin	9.97%
Profit Margin	7.29%
Free Cash Flow	$-4.50M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	0.52
Receiveable Turnover	1.67
Days Sales in Receivables	53.89
Return on Equity	8.51%
Return on Tangible Equity	12.22%
Return on Assets	1.91%
Return on Investments	2.56%
Book Value Per Share	$7.68
Free Cash Flow per Share	$-0.11
Operating Cash Flow per Share	$0.23

Data from Zacks Investment Research, Inc.